Skip to Content

Nektar Therapeutics NKTR

Trading Information

Previous Close Price
$0.71
Day Range
$0.660.73
52-Week Range
$0.413.08
Bid/Ask
$0.68 / $0.69
Market Cap
$126.60 Mil
Volume/Avg
1.8 Mil / 1.3 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.65
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, the company is focused on activating the immune system's natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
216

Comparables

Valuation

Metric
NKTR
TGTX
ALVR
Price/Earnings (Normalized)
28.26
Price/Book Value
0.9213.040.39
Price/Sales
1.6510.75
Price/Cash Flow
116.39
Price/Earnings
NKTR
TGTX
ALVR

Financial Strength

Metric
NKTR
TGTX
ALVR
Quick Ratio
7.226.46
Current Ratio
7.665.536.65
Interest Coverage
−11.01−0.99
Quick Ratio
NKTR
TGTX
ALVR

Profitability

Metric
NKTR
TGTX
ALVR
Return on Assets (Normalized)
−23.16%5.90%−47.97%
Return on Equity (Normalized)
−50.33%17.48%−58.92%
Return on Invested Capital (Normalized)
−32.77%17.27%−53.71%
Return on Assets
NKTR
TGTX
ALVR
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRCjc$544.0 Bil
VRTX
Vertex Pharmaceuticals IncRtjtph$108.7 Bil
REGN
Regeneron Pharmaceuticals IncPdwjytj$103.9 Bil
MRNA
Moderna IncDwvt$33.2 Bil
ARGX
argenx SE ADRFpk$23.4 Bil
BNTX
BioNTech SE ADRGylp$21.7 Bil
ALNY
Alnylam Pharmaceuticals IncDbktc$18.9 Bil
BMRN
Biomarin Pharmaceutical IncFjnfgbb$16.7 Bil
RPRX
Royalty Pharma PLC Class AHzghyv$13.5 Bil
INCY
Incyte CorpFbgybz$13.2 Bil

Sponsor Center